It’s time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an article appearing today in Clinical Microbiology Reviews, a journal of the American Society of Microbiology. Global emergence of several multidrug-resistant gut pathogens and the potential for crossover transmissions among different at-risk populations underscores the importance of prompt diagnosis, appropriate treatment, and the need to consider community-level education and testing.

Armida Labs, Inc., a University of California, Riverside startup company, has been awarded a $2.25 million Small Business Innovation Research grant from the National Cancer Institute of the National Institutes of Health. The grant will support preclinical investigational new drug (IND) application studies, which are critically required before human clinical trials can be initiated.

Penn Engineers are uncovering how the mechanics of tumors and the tiny messages cells send through extracellular vesicles work together to drive cancer progression, opening new paths for therapies and training the next generation of researchers to think across disciplines.